166 related articles for article (PubMed ID: 34997003)
1. Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer.
Kanno M; Yunokawa M; Nakabayashi M; Omi M; Ikki A; Mizusaki M; Nishimura M; Shimizu Y; Okamoto K; Tanaka Y; Fusegi A; Netsu S; Kurita T; Aoki Y; Tanigawa T; Matoda M; Okamoto S; Nomura H; Omatsu K; Sugiyama Y; Utsugi K; Takeshima N; Kanao H
Sci Rep; 2022 Jan; 12(1):166. PubMed ID: 34997003
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Features of Recurrent Endometrial Cancer in Japan: Chemotherapy Instead of Radiotherapy as Postoperative Adjuvant Treatment.
Iwase H; Furukawa S; Hirasawa T; Asai S; Ohara T; Hosonuma S; Endo S; Tazo Y; Sato H; Takada T; Arai M; Ikeda M; Shida M; Yoshioka N; Tozawa-Ono A; Suzuki N; Mikami M; Onda T
Int J Gynecol Cancer; 2018 Oct; 28(8):1616-1623. PubMed ID: 30095709
[TBL] [Abstract][Full Text] [Related]
3. An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.
Liang LW; Perez AR; Cangemi NA; Zhou Q; Iasonos A; Abu-Rustum N; Alektiar KM; Makker V
Int J Gynecol Cancer; 2016 Mar; 26(3):497-504. PubMed ID: 26825840
[TBL] [Abstract][Full Text] [Related]
4. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of peritoneal cytology in stage IA endometrial endometrioid carcinomas.
Wang L; Li L; Wu M; Lang J
Curr Probl Cancer; 2020 Apr; 44(2):100514. PubMed ID: 31753315
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer.
Aoki Y; Watanabe M; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K
Gynecol Oncol; 2004 Aug; 94(2):333-9. PubMed ID: 15297170
[TBL] [Abstract][Full Text] [Related]
7. Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database.
Seagle BL; Alexander AL; Lantsman T; Shahabi S
Am J Obstet Gynecol; 2018 Mar; 218(3):329.e1-329.e15. PubMed ID: 29223598
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
9. A qualitative systematic review of the significance of adjuvant therapy in patients with low-risk endometrial cancer presenting positive peritoneal cytology: a relevant study to the guideline update for endometrial cancer by the Japan society of gynecologic oncology guideline committee.
Shigeta S; Konno Y; Terai Y; Morisada T; Tokunaga H; Baba T; Kobayashi Y; Nagase S
Jpn J Clin Oncol; 2024 Feb; 54(2):217-220. PubMed ID: 37823222
[TBL] [Abstract][Full Text] [Related]
10. Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer.
Matsuo K; Nusbaum DJ; Matsuzaki S; Chang EJ; Roman LD; Wright JD; Harter P; Klar M
Gynecol Oncol; 2020 Oct; 159(1):43-51. PubMed ID: 32690393
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
[TBL] [Abstract][Full Text] [Related]
12. Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer.
Garg G; Gao F; Wright JD; Hagemann AR; Mutch DG; Powell MA
Gynecol Oncol; 2013 Jan; 128(1):77-82. PubMed ID: 23032094
[TBL] [Abstract][Full Text] [Related]
13. Postoperative adjuvant chemotherapy with cisplatin, cyclophosphamide, and anthracycline (doxorubicin, epirubicin, pirarubicin) for endometrial cancer.
Yahata H; Hirakawa T; Fujita T; Ariyoshi K; Sonoda K; Amada S; Kobayashi H; Nakano H
Int J Clin Oncol; 2004 Aug; 9(4):317-21. PubMed ID: 15375709
[TBL] [Abstract][Full Text] [Related]
14. Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy.
Mundt AJ; McBride R; Rotmensch J; Waggoner SE; Yamada SD; Connell PP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1145-53. PubMed ID: 11483323
[TBL] [Abstract][Full Text] [Related]
15. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
16. [Effects of postoperative chemotherapy on the prognosis of patients with high-risk early stage endometrial cancer].
Wen HW; Tian F; Ma L; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2009 Mar; 44(3):196-9. PubMed ID: 19570445
[TBL] [Abstract][Full Text] [Related]
17. Association Between Adjuvant Therapy and Survival in Stage II-III Endometrial Cancer: Influence of Malignant Peritoneal Cytology.
Matsuo K; Matsuzaki S; Nusbaum DJ; Roman LD; Wright JD; Harter P; Klar M
Ann Surg Oncol; 2021 Nov; 28(12):7591-7603. PubMed ID: 33797002
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus.
Kasamatsu T; Onda T; Katsumata N; Sawada M; Yamada T; Tsunematsu R; Ohmi K; Sasajima Y; Matsuno Y
Br J Cancer; 2003 Jan; 88(2):245-50. PubMed ID: 12610496
[TBL] [Abstract][Full Text] [Related]
19. Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer.
Matsuo K; Yabuno A; Hom MS; Shida M; Kakuda M; Adachi S; Mandelbaum RS; Ueda Y; Hasegawa K; Enomoto T; Mikami M; Roman LD
Gynecol Oncol; 2018 May; 149(2):301-309. PubMed ID: 29605499
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer.
Jeans EB; Breen WG; Mullikin TC; Looker BA; Mariani A; Keeney GL; Haddock MG; Petersen IA
Int J Gynecol Cancer; 2021 Jun; 31(6):859-867. PubMed ID: 33563642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
